Key result
High institutional BPA experience is linked to ~67% lower 30-day complications vs. low experience.
Why the study?
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension has rapidly expanded to less experienced centers in Japan, but objective criteria defining institutional expertise based on cumulative procedural experience remained undefined.
Does higher cumulative institutional procedural experience reduce 30-day major adverse events in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty?
Observational (n=3,708)
Yes
Does higher cumulative institutional procedural experience reduce 30-day major adverse events in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty?
Answers are grounded in this paper and cite their sources.
A cumulative institutional experience threshold of approximately 250 balloon pulmonary angioplasty procedures serves as a practical benchmark for achieving low stabilized 30-day complication rates in chronic thromboembolic pulmonary hypertension.
Background Balloon pulmonary angioplasty (BPA) is an established catheter-based treatment for chronic thromboembolic pulmonary hypertension. Since the safety of refined BPA techniques was reported in 2012, BPA has rapidly disseminated nationwide in Japan, with increasing adoption by centers with less experience. Although BPA is known to involve a learning curve, objective criteria defining institutional expertise based on cumulative procedural experience remain undefined. Purpose This study aimed to clarify institutional expertise in BPA based on cumulative procedural experience. Methods Using the Japanese Cardiovascular Disease All-Case Registry (2012–2022), we retrospectively analyzed 14,468 BPA procedures performed in 3,708 patients. Complications were defined as a composite of the following major adverse events within 30 days after the procedure: death, initiation of mechanical ventilation (including noninvasive positive pressure ventilation), initiation of extracorporeal membrane oxygenation, initiation of continuous hemodiafiltration, transfusion, cardiac tamponade, or surgery. Cumulative procedural experience for each procedure was defined as its chronological order number among BPA procedures performed at the same center. Cumulative procedural experience was categorized into tertiles (1–73, 74–324, ≥324 procedures) and evaluated using multivariable logistic regression. Nonlinear learning-curve effects were assessed using restricted cubic spline (RCS) modeling. A secondary analysis was performed among incident centers that initiated BPA in 2013 or later. Results Complication rates decreased stepwise with increasing cumulative procedural experience (low-experience 9.4%, intermediate-experience 5.4%, high-experience 2.6%; trend P < 0.001). This reduction was primarily driven by a lower incidence of mechanical ventilation, while transfusion also declined with increasing experience (trend P < 0.001 and P = 0.049, respectively). In multivariable analysis adjusting for age, sex, NYHA class, and procedural year, the high-experience group had significantly lower complication risk than the low-experience group (adjusted odds ratio 0.331, 95% CI 0.205–0.535). RCS analysis demonstrated a marked reduction in adjusted complication rate, with an elbow point at approximately 52 cumulative procedures, followed by a plateau around 264 procedures. Among incident centers (9,265 procedures), the elbow point was less distinct, whereas adjusted complication rate stabilized at low levels beyond approximately 250 cumulative procedures, consistent with findings in the overall cohort. Conclusions A cumulative procedural experience threshold of approximately 250 procedures may serve as a practical institutional benchmark for achieving low complication rates with BPA.
No takes yet. Share an insight, caveat, or question.
Takano et al. (2026) conducted an observational in Chronic thromboembolic pulmonary hypertension (n=3,708). High cumulative institutional procedural experience in balloon pulmonary angioplasty (≥324 procedures) vs. Low cumulative institutional procedural experience (1–73 procedures) was evaluated on Composite of major adverse events within 30 days after the procedure (death, initiation of mechanical ventilation, extracorporeal membrane oxygenation, continuous hemodiafiltration, transfusion, cardiac tamponade, or surgery) (OR 0.331, 95% CI 0.205-0.535, p=<0.001 for trend). High institutional BPA experience (≥324 procedures) was associated with lower 30-day complications than low experience.
Synapse has enriched 10 related papers. Consider them for comparative context: